387 related articles for article (PubMed ID: 26324925)
1. Parkin loss leads to PARIS-dependent declines in mitochondrial mass and respiration.
Stevens DA; Lee Y; Kang HC; Lee BD; Lee YI; Bower A; Jiang H; Kang SU; Andrabi SA; Dawson VL; Shin JH; Dawson TM
Proc Natl Acad Sci U S A; 2015 Sep; 112(37):11696-701. PubMed ID: 26324925
[TBL] [Abstract][Full Text] [Related]
2. PARIS induced defects in mitochondrial biogenesis drive dopamine neuron loss under conditions of parkin or PINK1 deficiency.
Pirooznia SK; Yuan C; Khan MR; Karuppagounder SS; Wang L; Xiong Y; Kang SU; Lee Y; Dawson VL; Dawson TM
Mol Neurodegener; 2020 Mar; 15(1):17. PubMed ID: 32138754
[TBL] [Abstract][Full Text] [Related]
3. Promotion of mitochondrial biogenesis via the regulation of PARIS and PGC-1α by parkin as a mechanism of neuroprotection by carnosic acid.
Lin CY; Huang YN; Fu RH; Liao YH; Kuo TY; Tsai CW
Phytomedicine; 2021 Jan; 80():153369. PubMed ID: 33070082
[TBL] [Abstract][Full Text] [Related]
4. PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson's disease.
Shin JH; Ko HS; Kang H; Lee Y; Lee YI; Pletinkova O; Troconso JC; Dawson VL; Dawson TM
Cell; 2011 Mar; 144(5):689-702. PubMed ID: 21376232
[TBL] [Abstract][Full Text] [Related]
5. PINK1 Primes Parkin-Mediated Ubiquitination of PARIS in Dopaminergic Neuronal Survival.
Lee Y; Stevens DA; Kang SU; Jiang H; Lee YI; Ko HS; Scarffe LA; Umanah GE; Kang H; Ham S; Kam TI; Allen K; Brahmachari S; Kim JW; Neifert S; Yun SP; Fiesel FC; Springer W; Dawson VL; Shin JH; Dawson TM
Cell Rep; 2017 Jan; 18(4):918-932. PubMed ID: 28122242
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of parkin in the substantia nigra of db/db and high-fat diet mice.
Khang R; Park C; Shin JH
Neuroscience; 2015 May; 294():182-92. PubMed ID: 25779963
[TBL] [Abstract][Full Text] [Related]
7. Defects in Mitochondrial Biogenesis Drive Mitochondrial Alterations in PARKIN-Deficient Human Dopamine Neurons.
Kumar M; Acevedo-Cintrón J; Jhaldiyal A; Wang H; Andrabi SA; Eacker S; Karuppagounder SS; Brahmachari S; Chen R; Kim H; Ko HS; Dawson VL; Dawson TM
Stem Cell Reports; 2020 Sep; 15(3):629-645. PubMed ID: 32795422
[TBL] [Abstract][Full Text] [Related]
8. Detrimental effects of oxidative losses in parkin activity in a model of sporadic Parkinson's disease are attenuated by restoration of PGC1alpha.
Siddiqui A; Rane A; Rajagopalan S; Chinta SJ; Andersen JK
Neurobiol Dis; 2016 Sep; 93():115-20. PubMed ID: 27185595
[TBL] [Abstract][Full Text] [Related]
9. Repression of rRNA transcription by PARIS contributes to Parkinson's disease.
Kang H; Shin JH
Neurobiol Dis; 2015 Jan; 73():220-8. PubMed ID: 25315684
[TBL] [Abstract][Full Text] [Related]
10. Parkin functionally interacts with PGC-1α to preserve mitochondria and protect dopaminergic neurons.
Zheng L; Bernard-Marissal N; Moullan N; D'Amico D; Auwerx J; Moore DJ; Knott G; Aebischer P; Schneider BL
Hum Mol Genet; 2017 Feb; 26(3):582-598. PubMed ID: 28053050
[TBL] [Abstract][Full Text] [Related]
11. AMP Kinase Activation is Selectively Disrupted in the Ventral Midbrain of Mice Deficient in Parkin or PINK1 Expression.
Hang L; Thundyil J; Goh GWY; Lim KL
Neuromolecular Med; 2019 Mar; 21(1):25-32. PubMed ID: 30411223
[TBL] [Abstract][Full Text] [Related]
12. Lack of Parkin Anticipates the Phenotype and Affects Mitochondrial Morphology and mtDNA Levels in a Mouse Model of Parkinson's Disease.
Pinto M; Nissanka N; Moraes CT
J Neurosci; 2018 Jan; 38(4):1042-1053. PubMed ID: 29222404
[No Abstract] [Full Text] [Related]
13. Deubiquitinase CYLD acts as a negative regulator of dopamine neuron survival in Parkinson's disease.
Pirooznia SK; Wang H; Panicker N; Kumar M; Neifert S; Dar MA; Lau E; Kang BG; Redding-Ochoa J; Troncoso JC; Dawson VL; Dawson TM
Sci Adv; 2022 Apr; 8(13):eabh1824. PubMed ID: 35363524
[TBL] [Abstract][Full Text] [Related]
14. Parkin is required for exercise-induced mitophagy in muscle: impact of aging.
Chen CCW; Erlich AT; Crilly MJ; Hood DA
Am J Physiol Endocrinol Metab; 2018 Sep; 315(3):E404-E415. PubMed ID: 29812989
[TBL] [Abstract][Full Text] [Related]
15. Synaptotagmin-11 is a critical mediator of parkin-linked neurotoxicity and Parkinson's disease-like pathology.
Wang C; Kang X; Zhou L; Chai Z; Wu Q; Huang R; Xu H; Hu M; Sun X; Sun S; Li J; Jiao R; Zuo P; Zheng L; Yue Z; Zhou Z
Nat Commun; 2018 Jan; 9(1):81. PubMed ID: 29311685
[TBL] [Abstract][Full Text] [Related]
16. The Absence of Parkin Does Not Promote Dopamine or Mitochondrial Dysfunction in PolgA
Scott L; Karuppagounder SS; Neifert S; Kang BG; Wang H; Dawson VL; Dawson TM
J Neurosci; 2022 Dec; 42(49):9263-9277. PubMed ID: 36280265
[TBL] [Abstract][Full Text] [Related]
17. PARIS farnesylation prevents neurodegeneration in models of Parkinson's disease.
Jo A; Lee Y; Kam TI; Kang SU; Neifert S; Karuppagounder SS; Khang R; Kang H; Park H; Chou SC; Oh S; Jiang H; Swing DA; Ham S; Pirooznia S; Umanah GKE; Mao X; Kumar M; Ko HS; Kang HC; Lee BD; Lee YI; Andrabi SA; Park CH; Lee JY; Kim H; Kim H; Kim H; Cho JW; Paek SH; Na CH; Tessarollo L; Dawson VL; Dawson TM; Shin JH
Sci Transl Med; 2021 Jul; 13(604):. PubMed ID: 34321320
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial Quality Control via the PGC1α-TFEB Signaling Pathway Is Compromised by Parkin Q311X Mutation But Independently Restored by Rapamycin.
Siddiqui A; Bhaumik D; Chinta SJ; Rane A; Rajagopalan S; Lieu CA; Lithgow GJ; Andersen JK
J Neurosci; 2015 Sep; 35(37):12833-44. PubMed ID: 26377470
[TBL] [Abstract][Full Text] [Related]
19. Parkin interacting substrate phosphorylation by c-Abl drives dopaminergic neurodegeneration.
Kim H; Shin JY; Jo A; Kim JH; Park S; Choi JY; Kang HC; Dawson VL; Dawson TM; Shin JH; Lee Y
Brain; 2021 Dec; 144(12):3674-3691. PubMed ID: 34581802
[TBL] [Abstract][Full Text] [Related]
20. Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson's disease.
Panicker N; Kam TI; Wang H; Neifert S; Chou SC; Kumar M; Brahmachari S; Jhaldiyal A; Hinkle JT; Akkentli F; Mao X; Xu E; Karuppagounder SS; Hsu ET; Kang SU; Pletnikova O; Troncoso J; Dawson VL; Dawson TM
Neuron; 2022 Aug; 110(15):2422-2437.e9. PubMed ID: 35654037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
